List of Balcoltra drug patents

Balcoltra is owned by Avion Pharms.

Balcoltra contains Ethinyl Estradiol; Levonorgestrel.

Balcoltra has a total of 1 drug patent out of which 0 drug patents have expired.

Balcoltra was authorised for market use on 09 January, 2018.

Balcoltra is available in tablet;oral dosage forms.

Balcoltra can be used as administration of ferrous bisglycinate tablets.

The generics of Balcoltra are possible to be released after 01 June, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7838042 AVION PHARMS Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions
Jun, 2027

(4 years from now)

Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 09 January, 2018

Treatment: Administration of ferrous bisglycinate tablets

Dosage: TABLET;ORAL

How can I launch a generic of BALCOLTRA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in